⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.
Medium-Chain Triglycerides (MCT)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-29 — Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.: C. elegans mechanistic study: α-synuclein lipid binding and condensate formation progressively deplete triglycerides and disrupt lipid droplets and mitochondria with age; dietary MCT supplementation (or blocking long-chain unsaturated fatty acid synthesis) rescues motility and toxicity phenotypes, with a supporting observation of lower plasma TAGs in Parkinson’s cohorts. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.
29-sep-2026
novelty 3
per-area 3
strengthens